SCDM CCDM Exam Dumps

To monitor site variability in eligibility screening, you must analyze the number of subjects screened versus the number of subjects enrolled at each site. This allows identification of sites that are over- or under-screening relative to their enrollment yield.

The GCDMP (Chapter: Data Quality Assurance and Metrics) emphasizes that screening-to-enrollment ratios are critical indicators of protocol compliance and data quality. Sites with unusually low conversion rates may have unclear understanding of inclusion/exclusion criteria, requiring targeted training or monitoring.

Other options (A, C, D) provide enrollment metrics but do not reveal screening efficiency or variability, which depend on both screening and enrollment data.

Thus, option B correctly identifies the data necessary for monitoring eligibility screening performance across sites.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Data Quality Assurance and Metrics, Section 5.4 -- Site Performance Metrics

ICH E6(R2) GCP, Section 5.18 -- Monitoring and Site Oversight Requirements

RACI is a project management and governance framework used to define roles and responsibilities within a project. Each letter represents a distinct role type:

Responsible (R): The person(s) who perform the work or execute the task.

Accountable (A): The individual ultimately answerable for the task's completion and success (only one per activity).

Consulted (C): Subject matter experts who provide input or guidance before decisions are made.

Informed (I): Individuals kept up to date on progress or outcomes but not directly involved in execution.

The RACI model ensures clarity in ownership and accountability, preventing duplication of effort or responsibility confusion. It is a key component of the GCDMP (Chapter: Project Management in Data Management) for ensuring clear delegation and communication within clinical data management teams.

Hence, option D is correct.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Project Management in Data Management, Section 5.1 -- Roles, Responsibilities, and RACI Matrices

Project Management Institute (PMI) Framework -- Responsibility Assignment Matrices (RACI)

ICH E6(R2) GCP, Section 5.1.1 -- Defined Roles and Quality Oversight Responsibilities

In a discrepancy management workflow, ''Received from site and not yet reviewed'' is not a resolution type --- it represents a status, not a final resolution outcome.

According to the GCDMP (Chapter: Data Validation and Cleaning), resolution types describe how a data discrepancy was finalized or addressed, such as:

Resolved with data correction,

Confirmed as correct (no change required),

Self-evident correction applied by data management, or

Unresolvable discrepancies documented.

In contrast, statuses describe the stage of the query (e.g., open, sent, answered, pending review, closed). ''Received from site and not yet reviewed'' indicates an intermediate workflow state where the response awaits validation by data management.

Proper classification of resolution types is essential for performance reporting, audit readiness, and ensuring the traceability of query management actions under ICH E6 (R2) and FDA 21 CFR Part 11.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Validation and Cleaning, Section 5.3 -- Discrepancy Resolution Lifecycle

ICH E6 (R2) Good Clinical Practice, Section 5.5.3 -- Data Handling and Record Management

FDA 21 CFR Part 11 -- Electronic Records; Audit Trails and Discrepancy Tracking Requirements

The key deliverables for User Acceptance Testing (UAT) are the Test Plan, Test Scripts, and Test Results.

According to the GCDMP (Chapter: Database Design and Validation), UAT is the final validation step before a clinical database is released for production. It confirms that the system performs according to user requirements and protocol specifications.

The deliverables include:

UAT Test Plan: Defines testing objectives, scope, acceptance criteria, and responsibilities.

UAT Test Scripts: Provide step-by-step instructions for testing database functionality, edit checks, and workflows.

UAT Test Results: Document actual test outcomes versus expected outcomes, including any deviations and their resolutions.

These deliverables form part of the system validation documentation required under FDA 21 CFR Part 11 and ICH E6 (R2) to demonstrate that the database has been properly validated.

Project Plans (option A) and Training (option B) occur in earlier phases, while eCRF Completion Guidelines (option D) support site data entry, not system validation.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Database Design and Validation, Section 5.3 -- User Acceptance Testing Deliverables

FDA 21 CFR Part 11 -- Validation Documentation Requirements

ICH E6 (R2) Good Clinical Practice, Section 5.5.3 -- System Validation Records

Case Report Form Completion Guidelines (CCGs) are essential study documents that instruct site staff on how to complete each field of the CRF correctly. A minimum requirement for CCGs, according to Good Clinical Data Management Practices (GCDMP, Chapter: CRF Design and Data Collection), is that they must include version control.

Option A describes an important design consideration but not a minimum compliance requirement. Option B is inaccurate, as CCGs must be approved and implemented before data collection begins, not after. Option D includes an irrelevant stakeholder (Marketing).

Therefore, option C---''CCGs must include a version control on the updated document''---is correct and compliant with CCDM and GCP standards.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: CRF Design and Data Collection, Section 4.3 -- Development and Maintenance of CRF Completion Guidelines

ICH E6(R2) GCP, Section 8.2.1 -- Essential Documents and Version Control Requirements